Tucson-based Scintillation Nanotechnologies, Inc. has been selected by the Society for Laboratory Automation and Screening (SLAS) to be included on “Innovation AveNEW” at the society’s upcoming 2022 International Conference and Exhibition. The company – a startup founded to commercialize inventions stemming from research at the University of Arizona – has developed next generation nanoparticles for the detection of radiolabeled compounds directly in aqueous samples, eliminating the need for extensive sample preparation and sample destruction that are experienced with competing products. The unique chemical and physical properties of the company’s aquaSCINTTM and nanoSPATM products give researchers unprecedented insight into drug uptake, binding, and distribution while saving time and reducing costly hazardous waste .
“We are pleased to have been selected to exhibit our novel nanoparticle technology at the SLAS conference” said Dr. Colleen Janczak, Scintillation Nanotechnologies’ Head of Research and Development. “Innovation AveNew highlights the latest developments in automation and screening for life sciences and we are proud to be included. Our products offer breakthrough capabilities in laboratory screening and we are anxious to share these capabilities with the researchers and life science partners who attend the SLAS conference.”
The Society for Laboratory Automation and Screening International Conference and Exhibition will be held at the Boston Convention Center February 5 – 9, 2022. For more information about SLAS 2022, visit https://www.slas.org/events-calendar/slas2022-international-conference-and-exhibition/
About Scintillation Nanotechnologies, Inc.
Scintillation Nanotechnologies, Inc. is a company dedicated to revolutionizing the sensitivity, selectivity, and resolution of chemical and biological assays through constant innovation in nanoscale radioisotope detectors, enabling breakthrough discoveries in biological, chemical, and environmental systems. It is our mission to bring previously unattainable measurement capabilities to the laboratory, enabling researchers across the full range of scientific endeavor to ask and answer previously impossible research questions, opening the door to discoveries that expand humankind’s knowledge for the betterment of the planet and the human condition
For more information about Scintillation Nanotechnologies, visit https://sntnano.com.
About SLAS.
SLS (Society for Laboratory Automation and Screening) is an international professional society of academic, industry and government life sciences researchers and the developers and providers of laboratory automation technology. The SLAS mission is to bring together researchers in academia, industry and government to advance life sciences discovery and technology via education, knowledge exchange and global community building.
Contact
Chuck Phillips
Chief Executive Officer
Telephone: +1 800-759-0258